Every Form 4 that Natera, Inc. (NTRA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow NTRA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NTRA filings page.
Natera, Inc. executive chairman Matthew Rabinowitz reported open-market sales of a total of 100,000 shares of common stock. The transactions took place on June 12 and June 15, 2026 at weighted average prices within ranges from $208.88 to $219.98 per share, according to accompanying footnotes.
The filing states that these sales were effected under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026. Following the transactions, Rabinowitz directly holds 2,277,843 common shares, with an additional 5,000 shares held indirectly by his spouse, indicating he retains a substantial equity position in the company.
Natera, Inc. director Marcus Gail Boxer reported an exercise-and-sell transaction in company stock. On June 5, 2026, he exercised stock options for 11,000 shares of Common Stock at an exercise price of $22.83 per share and sold 11,000 shares in multiple open-market trades.
The sales were executed in several tranches at weighted average prices around $216–$219 per share, with detailed price ranges disclosed in the notes. Following these transactions, Boxer directly owns 6,183 shares of Natera Common Stock, and the option position related to these 11,000 shares is fully exercised.
Natera, Inc. CEO and President Steven Leonard Chapman reported open-market sales of 41,124 shares of common stock on June 4, 2026. The 14 separate transactions were executed at weighted-average prices, with footnotes showing sale prices ranging from about $211.89 to $227.21 per share under a pre-arranged Rule 10b5-1 trading plan adopted and later amended by the reporting person. After these sales, Chapman continues to hold 108,743 shares of Natera common stock directly.
Natera, Inc. president of clinical diagnostics Solomon Moshkevich sold 3,000 shares of common stock in open-market transactions. The trades on June 1, 2026 were executed under a pre-arranged Rule 10b5-1 trading plan and at various prices. After these sales, he directly holds 137,643 shares.
Rubin Eric H reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. director Eric H. Rubin received a grant of 2,124 shares of Common Stock in the form of Restricted Stock Units as compensation. The award is valued at $425,000 and increases his direct holdings to 2,129 shares.
The RSUs will vest in three equal annual installments beginning on March 26, 2027. Each RSU represents a contingent right to receive one share of Natera’s Common Stock, so Rubin will receive the underlying shares over time as the units vest.
Natera, Inc. director Roelof Botha reported a series of open-market sales totaling 78,000 shares of Natera common stock on June 1, 2026, executed through estate planning vehicles. The reported weighted average sale prices ranged from about $218 to $224 per share across multiple trades. Following these transactions, estate planning vehicles associated with Botha held 1,076,198 shares indirectly, while he also reported 2,894 shares held directly.
Natera, Inc. president of clinical diagnostics Solomon Moshkevich reported an open-market sale of 1,652 shares of common stock at $202.8398 per share. According to the footnote, the sale was made to satisfy tax withholding obligations tied to RSU vesting under a written instruction intended to meet Rule 10b5-1(c) conditions. Following the transaction, he directly holds 140,643 shares.
Natera, Inc. reported that its President and Chief Business Officer, John Fesko, sold 1,438 shares of common stock in an open-market transaction at an average price of $202.8398 per share. The sale was made to cover tax withholding obligations related to the vesting of restricted stock units and followed written instructions intended to satisfy Rule 10b5-1(c) conditions. After this transaction, Fesko directly holds 185,782 shares of Natera common stock.
Natera, Inc. co-founder and director Sheena Jonathan reported 13 sales totaling 4,650 shares of Natera common stock on May 8 and May 13, 2026, at weighted-average prices between $199.00 and $210.3450 per share, effected under Rule 10b5-1 trading plans. After these trades, she holds 252,502 shares directly, with 19,532 shares held by Caraluna 1 Trust and 19,532 shares by Caraluna 2 Trust; the trust shares are held for beneficiaries, and Jonathan disclaims beneficial ownership of those securities.
Natera, Inc. Executive Chairman Matthew Rabinowitz reported compensation-related stock activity. On May 5, 2026, he received 2,389 fully vested Restricted Stock Units (RSUs), each representing one share of common stock. Around the same time, he sold 7,708 shares of common stock in multiple open-market transactions at prices between $205.22 and $241.39.
According to the footnotes, these sales were executed to satisfy tax withholding and remittance obligations arising from RSU vesting and were carried out under written instructions intended to meet the affirmative defense conditions of Rule 10b5-1(c). After these transactions, he directly owned 2,378,791 shares of Natera common stock, with an additional 5,000 shares held indirectly by his spouse.
Natera, Inc. chief financial officer Michael Burkes Brophy reported selling a total of 795 shares of Common Stock in open-market transactions, including 313 shares at $206.16 on May 1, 2026 and 482 shares at $210.49 on May 4, 2026. According to the footnotes, these sales were carried out to satisfy tax withholding obligations related to vesting RSUs and were executed under written instructions and a Rule 10b5-1 trading plan. After these transactions, he directly holds 57,496 shares.
Natera, Inc. director and co-founder Jonathan Sheena reported a small sale of common stock tied to equity compensation. On the reported date, 107 shares were sold at $206.16 per share to satisfy tax withholding and remittance obligations related to vesting RSUs, under a written instruction intended to meet Rule 10b5-1(c) conditions. After this transaction, Sheena held 255,652 shares of Natera common stock directly. Separate trusts identified as Caraluna 1 Trust and Caraluna 2 Trust each held 20,282 shares for their beneficiaries, and Sheena disclaimed beneficial ownership of those trust-held shares.
Natera, Inc. executive Solomon Moshkevich, President of Clinical Diagnostics, sold a total of 3,405 shares of common stock on May 1, 2026 in multiple open-market transactions, at prices around $200–$207 per share.
According to the disclosures, part of the sale was made to satisfy tax withholding and remittance obligations tied to the vesting of restricted stock units, under written instructions intended to meet Rule 10b5-1(c) conditions. Additional shares were sold under a separate Rule 10b5-1 trading plan adopted on November 26, 2024. After these transactions, he directly holds 142,295 shares of Natera common stock.
Natera, Inc. president and chief business officer John Fesko reported an open-market sale of 291 shares of common stock at $206.16 per share. After the transaction, he directly held 187,220 shares. The footnote states the sale was made to cover tax withholding obligations from RSU vesting under a written instruction intended to satisfy Rule 10b5-1(c) conditions.
Natera, Inc. director and CEO Steven Leonard Chapman reported an open-market sale of 902 shares of Common Stock on May 1, 2026 at $206.16 per share. According to a footnote, the sale was made to satisfy tax withholding and remittance obligations tied to vesting RSUs under a pre-arranged instruction intended to meet Rule 10b5-1(c) conditions. After this transaction, he directly owned 149,867 shares of Natera common stock.
Natera, Inc. disclosed that its Secretary and Chief Legal Officer, Daniel Rabinowitz, executed an open-market sale of 330 shares of common stock on May 1, 2026 at $206.16 per share. After this transaction, he directly held 222,694 shares.
According to the footnote, the sale was made to cover tax withholding and remittance obligations related to the vesting of restricted stock units and was carried out under a written instruction intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Natera, Inc.'s Chief Financial Officer, Michael Burkes Brophy, reported selling a total of 5,063 shares of Common Stock in open-market transactions on April 27 and April 29, 2026, at prices around the low-$200 to high-$190 range per share.
According to the footnotes, these sales were carried out to cover tax withholding and remittance obligations tied to the vesting of Restricted Stock Units granted in 2023 and 2024, and were executed under a pre-arranged Rule 10b5-1 trading plan. After the transactions, he directly holds 58,291 shares, indicating he retains a substantial equity stake.
Natera, Inc. CEO and President Steven Leonard Chapman reported selling a total of 5,838 shares of Natera common stock in open-market transactions on April 27, 2026. The footnotes state these sales were made to cover tax withholding and remittance obligations tied to the vesting of Restricted Stock Units and were executed under written instructions intended to satisfy Rule 10b5-1(c) affirmative defense conditions.
Natera, Inc. President and Chief Business Officer John Fesko sold a total of 1,688 shares of common stock on April 27, 2026 in two open-market transactions at prices of about $204 per share. According to the disclosure, these sales were executed to satisfy tax withholding and remittance obligations arising from the vesting of Restricted Stock Units and were carried out under written instructions intended to meet the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
Natera, Inc. president Solomon Moshkevich reported routine share sales tied to tax withholding obligations. On April 27, 2026, he sold a total of 2,182 shares of Natera common stock in open-market transactions at prices around $204 per share.
The footnotes explain that both sales were executed solely to cover tax withholding and remittance arising from the vesting of Restricted Stock Units granted in January 2023 and January 2024. The transactions were carried out under written instructions intended to meet the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
Natera, Inc. reported that its Secretary and Chief Legal Officer, Daniel Rabinowitz, sold a total of 1,861 shares of common stock in open‑market transactions. The sales, at prices of $204.39 and $203.75 per share, were made to satisfy tax withholding and remittance obligations arising from the vesting of Restricted Stock Units.
According to the filing, these transactions were executed under written instructions intended to meet the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, tied to stock unit agreements granted in January 2023 and January 2024. After these sales, Rabinowitz directly holds 223,024 shares of Natera common stock.
Natera, Inc. director and co‑founder Sheena Jonathan reported open‑market sales of 3,544 shares of Common Stock on April 27 and April 29, 2026, at prices around $196–$204 per share. After these trades, she directly holds 255,711 shares of Natera common stock.
Footnotes explain that certain sales were made to cover tax withholding and remittance obligations tied to the vesting of Restricted Stock Units and were effected pursuant to written instructions intended to satisfy Rule 10b5‑1(c) under the Exchange Act, including a trading plan adopted on December 11, 2024. Additional shares are held by the Caraluna 1 Trust and Caraluna 2 Trust, and Sheena Jonathan disclaims beneficial ownership of those trust securities.
Natera, Inc. director Herm Rosenman reported receiving equity-based compensation in the form of restricted stock units (RSUs). The filing shows two acquisitions of common stock via RSU awards on April 24, 2026, recorded at no cash cost per share to him.
One RSU grant was issued in lieu of quarterly board retainer fees of $23,750 and was fully vested at issuance, effectively converting a cash fee into share-based pay. A separate RSU award vests 25% immediately, with the remainder vesting in three equal quarterly installments, adding time-based incentives to his compensation.
Marcus Gail Boxer reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. director Marcus Gail Boxer reported receiving two grants of Restricted Stock Units (RSUs) on April 24, 2026 as equity compensation. One award of 222 RSUs was issued in lieu of quarterly board retainer fees of $21,875 and was fully vested at issuance. A separate grant of 108 RSUs provides that 25% vests immediately, with the remainder vesting in three equal quarterly installments. The filing shows Boxer's direct holdings after these transactions as 6,183 and 5,961 shares of common stock in the respective lines.
Chapman Rowan E reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. director Rowan E. Chapman reported two grants of common stock in the form of Restricted Stock Units (RSUs). One grant covers 222 RSUs issued in lieu of quarterly board retainer fees of $23,125, and these RSUs were fully vested at issuance. A second grant covers 114 RSUs, with 25% vesting immediately and the remaining RSUs vesting in three equal quarterly installments thereafter. Each RSU represents a contingent right to receive one share of Natera common stock, and the filing characterizes both transactions as awards rather than open-market purchases.
BOTHA ROELOF reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. director Roelof Botha reported stock-based compensation and updated holdings. On April 24, 2026, he received two grants of Common Stock in the form of Restricted Stock Units (RSUs), with awards of 222 and 132 shares at a stated price of $0.00 per share.
Footnotes explain one RSU grant was issued in lieu of quarterly board retainer fees of $26,875 and was fully vested at issuance, while another vests 25% immediately and the balance in three equal quarterly installments. After these awards, Form 4 shows direct holdings of 2,894 and 2,672 Common Stock shares in the respective accounts, plus an additional 1,154,198 shares held indirectly through estate planning vehicles.
Rubin Eric H reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. director Eric H. Rubin received a grant of 5 shares of common stock in the form of Restricted Stock Units (RSUs). These RSUs were issued in lieu of $1,125 in quarterly retainer fees for his Board service and were fully vested at issuance. Each RSU represents the right to receive one share of Natera common stock, and Rubin now holds 5 shares directly following this award.
Williams Brinkley Ruth reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. director Ruth Williams Brinkley received a grant of 86 Restricted Stock Units (RSUs) of common stock on April 24, 2026. These RSUs were issued in lieu of $17,500 in quarterly board retainer fees and were fully vested at issuance.
Each RSU represents the right to receive one share of Natera common stock, bringing her direct holdings to 5,475 shares after the transaction. This is a compensation-related equity award rather than an open-market share purchase or sale.
Bertagnolli Monica reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. director Monica Bertagnolli received an equity grant rather than cash fees for board service. She was issued 83 fully vested Restricted Stock Units (RSUs) on common stock in lieu of quarterly retainer fees of $16,875. Each RSU equals one share of common stock, bringing her direct holdings to 5,374 shares after this grant.
Baynes Roy D. reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. director Roy D. Baynes received a grant of 83 shares of common stock in the form of Restricted Stock Units. These RSUs were issued in lieu of quarterly board retainer fees of $16,875 and were fully vested at issuance. Following this award, Baynes directly holds 18,512 shares of Natera common stock. Each RSU represents a right to receive one share of common stock, so the grant functions as non-cash, stock-based compensation for his board service.
Natera, Inc. director and co-founder Jonathan Sheena reported indirect open-market sales of common stock by family trusts associated with him. The trusts sold a total of 1,500 shares on April 17, 2026 in two transactions at weighted average prices of about $199.59 and $199.66 per share, under a pre-arranged Rule 10b5-1 trading plan adopted on June 7, 2024. The sales were executed by the Caraluna 1 and Caraluna 2 Trusts, which hold the shares for trust beneficiaries, and Sheena disclaims beneficial ownership of those securities. Following these transactions, the filing shows 259,255 Natera shares held directly by Sheena and 20,282 shares reported as held indirectly through each trust.
Natera, Inc. Executive Chairman Matthew Rabinowitz exercised stock options and used shares to cover taxes. He exercised options to acquire 58,292 shares of Common Stock at an exercise price of $9.59 per share. To satisfy tax obligations, 27,610 shares of Common Stock were withheld at $204.87 per share. Following these transactions, he held 2,383,162 shares of Common Stock directly, plus 5,000 shares held indirectly by his spouse.
Natera, Inc. reported that its Secretary and Chief Legal Officer, Daniel Rabinowitz, conducted open-market sales of company common stock. On April 1, 2026, he sold a total of 8,400 shares at weighted average prices within disclosed ranges between $200.47 and $205.50 per share under a pre-arranged Rule 10b5-1 trading plan. Following these sales, he continued to hold 224,885 shares of Natera common stock directly.
Natera, Inc. executive Solomon Moshkevich reported selling 3,000 shares of Common Stock in open-market transactions. On April 1, 2026, he executed three sales of 1,048, 1,000, and 952 shares at weighted average prices of $201.3206, $202.3638, and $203.3106 per share.
The sales were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on November 26, 2024, indicating they were scheduled in advance. After these transactions, Moshkevich directly owns 147,882 shares of Natera common stock.
Natera, Inc. Executive Chairman Matthew Rabinowitz exercised stock options to acquire 41,708 shares of Common Stock. He exercised a fully exercisable option with a strike price of $9.59 per share, converting it into 41,708 Common shares on a one-for-one basis.
Following the transaction, he directly holds 2,352,480 shares of Natera Common Stock and 58,292 stock options. In addition, 5,000 Common shares are reported as indirectly owned by his spouse.
Natera, Inc. director and co-founder Jonathan Sheena reported open-market sales totaling 4,570 shares of common stock. On March 18 and March 20, 2026, shares were sold at prices generally around $196 to $201 per share through multiple transactions.
A portion of the sales was made from direct holdings, leaving 259,255 shares held directly afterward. Additional sales were conducted by Caraluna 1 Trust and Caraluna 2 Trust, which together held 21,032 shares each after the transactions, and are described as held for the benefit of trust beneficiaries, with Sheena disclaiming beneficial ownership.
Footnotes state that the sales were executed under pre-arranged Rule 10b5-1 trading plans adopted on June 7, 2024 and December 11, 2024, indicating the timing was set in advance.
Natera, Inc. director Rowan E. Chapman sold 122 shares of Common Stock in an open-market transaction at $191.38 per share. The sale occurred on March 13, 2026 and was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 12, 2025.
Following this sale, Chapman directly holds 5,752 Natera shares, indicating that the transaction covers only a small portion of his reported stake.
Natera, Inc. executive chairman Matthew Rabinowitz exercised stock options to acquire 200,000 shares of common stock at an exercise price of $9.59 per share, then sold 200,000 shares in multiple open-market transactions. The sales were executed at weighted average prices generally between about $186 and $198 per share.
According to the filing, all sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on December 11, 2025. After these transactions, Rabinowitz directly holds 2,310,772 shares of Natera common stock, with an additional 5,000 shares held indirectly by his spouse.
Natera, Inc. chief financial officer Michael Burkes Brophy reported two stock transactions. On March 9, 2026, he received 1,968 fully vested RSUs, each representing one share of common stock, as a stock award with no cash paid per share.
On March 10, 2026, he sold 785 shares of common stock at $204.1327 per share to cover tax withholding and remittance obligations related to the RSU vesting, under written instructions intended to satisfy Rule 10b5-1(c). After these transactions, he directly held 63,354 shares of Natera common stock.
Natera, Inc. CEO and president Steven Leonard Chapman reported a compensation-related share grant and a linked sale. On March 9, 2026, he received 5,623 fully vested Restricted Stock Units (RSUs), each representing one share of common stock. On March 10, 2026, he executed an open-market sale of 5,623 shares at an average price of $204.1327 per share, with the sale described as being partially to satisfy tax withholding obligations and carried out under a written instruction intended to meet Rule 10b5-1(c) conditions. After these transactions, he directly holds 156,607 shares of Natera common stock.
Natera, Inc. executive Daniel Rabinowitz, the Secretary and Chief Legal Officer, reported routine equity compensation activity and related share sales. He received a fully vested grant of 1,745 Restricted Stock Units, each representing one share of common stock. The next day, he sold 1,745 common shares in an open-market transaction at an average price of $204.1327 per share, leaving him with 233,285 shares of common stock held directly after the sale.
According to the disclosure, the sale was partially conducted to cover tax withholding and remittance obligations tied to the RSU vesting and was executed under written instructions intended to qualify for the Rule 10b5-1(c) affirmative defense, indicating a pre-arranged trading framework rather than an opportunistic trade.
Natera, Inc. director and co-founder Sheena Jonathan reported a small mix of stock compensation and related tax selling. On March 9, 2026, she received 258 shares of Common Stock as fully vested Restricted Stock Units granted at $0.0000 per share.
On March 10, 2026, she sold 127 shares of Common Stock at an average price of $204.1327 per share. The filing states this sale was made to satisfy tax withholding and remittance obligations tied to the RSU vesting and was executed under written instructions intended to qualify under Rule 10b5‑1. After these transactions, she directly owned 262,325 shares of Common Stock, with additional shares held in Caraluna 1 Trust and Caraluna 2 Trust for which she disclaims beneficial ownership.
Natera, Inc. reported that its president and chief business officer, John Fesko, received a grant of 1,774 fully vested restricted stock units (RSUs), each representing one share of common stock. These RSUs were issued as a stock award with no cash price per share.
On the following day, Fesko executed an open-market sale of 707 shares of common stock at $204.1327 per share. According to the footnotes, this sale was carried out to satisfy tax withholding and remittance obligations related to the RSU vesting and was made pursuant to written instructions intended to meet Rule 10b5-1(c) conditions. After these transactions, Fesko directly held 189,199 shares of Natera common stock.
Natera, Inc. president of clinical diagnostics Solomon Moshkevich reported compensation-related stock activity. He received 1,774 fully vested Restricted Stock Units (RSUs), each representing the right to one share of Natera common stock. The next day, he sold 915 shares of common stock at $204.1327 per share.
The sale was carried out to satisfy tax withholding and remittance obligations arising from the RSU vesting and was made under a written instruction intended to meet the Rule 10b5-1(c) affirmative defense conditions in his March 9, 2026 stock unit agreement. After these transactions, he directly held 150,882 shares of Natera common stock.
Natera, Inc. executive Daniel Rabinowitz, the Secretary and Chief Legal Officer, exercised options to acquire 5,598 shares of common stock at an exercise price of $19.68 per share. These options were fully exercisable.
On the same date, he sold a total of 8,398 shares of Natera common stock in open-market transactions at weighted-average prices disclosed between $193.27 and $198.32 per share, pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2025. After these transactions, he continued to hold 233,285 shares of Natera common stock directly.
Natera, Inc. director and co-founder Jonathan Sheena reported mixed equity activity in Natera stock. On March 2, 2026, he completed open-market sales totaling 3,070 shares of Common Stock at weighted average prices ranging from $198.24 to $202.85 per share under a pre-arranged Rule 10b5-1 trading plan adopted on June 7, 2024. Following these sales, his directly held stake reported in this filing was 262,194 shares.
On February 27, 2026, Sheena also received a grant of 2,103 Restricted Stock Units (RSUs), each representing a contingent right to one share of Common Stock. The RSUs vest over four years, with 25% vesting on March 1, 2027 and the rest in 12 equal quarterly installments. The filing also notes indirect holdings in trusts for beneficiaries, for which he disclaims beneficial ownership.
Natera, Inc. director and CEO Steven Leonard Chapman reported both an equity award and share sales. On February 27, 2026, he received 37,401 Restricted Stock Units (RSUs), which vest over four years starting March 1, 2027, with each RSU representing one common share. On March 2, 2026, he sold a total of 3,950 shares of common stock in three open-market transactions at weighted average prices around $199–$201 per share, executed under a pre-established Rule 10b5-1 trading plan adopted December 11, 2023 and amended December 2, 2024. Following these transactions, he directly held 156,607 common shares.
Natera, Inc. president of clinical diagnostics Solomon Moshkevich reported multiple equity transactions. On March 2, 2026, he exercised stock options for 5,125 shares of common stock at a stated price of $9.5900 per share and received the underlying shares. That same day he sold a total of 3,000 shares of common stock in open‑market transactions in three blocks at weighted average prices of $198.8338, $200.1073, and $200.9679 per share under a pre‑arranged Rule 10b5‑1 trading plan adopted on November 26, 2024, leaving 150,023 shares held directly after the reported sales. On February 27, 2026, he also received a grant of 10,051 restricted stock units, each representing one share of common stock, which vest over four years, with 25% vesting on March 1, 2027 and the rest vesting in 12 equal quarterly installments thereafter.
Rabinowitz Matthew reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. executive chairman Matthew Rabinowitz received an equity award of 29,920 restricted stock units (RSUs). The RSUs were granted on February 27, 2026 at no cash cost and each RSU represents one share of common stock. Vesting begins March 1, 2027, when 25% vests, with the remainder vesting in 12 equal quarterly installments over the following three years.
RABINOWITZ DANIEL reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. reported that its Secretary and Chief Legal Officer, Daniel Rabinowitz, received a grant of 12,272 restricted stock units (RSUs) of common stock on February 27, 2026. These RSUs vest over four years, with 25% vesting on March 1, 2027 and the remainder in 12 equal quarterly installments. Each RSU represents the right to receive one share of Natera common stock, bringing his directly owned total to 236,085 shares after the award.